Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate


You May Also Like

Avant Diagnostics Announces Data Presentations at 2016 ASCO Annual Meeting

SCOTTSDALE, Ariz. and GAITHERSBERG, Md., May 19, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. ...

Aclaris Therapeutics, Inc. Appoints Kevin Scott as Vice President of Sales

MALVERN, Pa., May 05, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage ...